Alector (ALEC) Accounts Payables (2018 - 2026)
Alector's (ALEC) quarterly Accounts Payables came in at $2.3 million in Q2 2026, up 2.98% year-over-year from $2.2 million in Q2 2025, and up 60.44% quarter-over-quarter from $1.4 million in Q1 2026.
Analysis
Alector (ALEC) Accounts Payables (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Accounts Payables for 9 consecutive years, with $2.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Accounts Payables rose 2.98% year-over-year to $2.3 million in Q2 2026; TTM through Jun 2026 was $2.3 million, a 2.98% increase from a year earlier, with the FY2025 full-year figure at $1.7 million, down 23.66% from the prior year.
- Accounts Payables was $2.3 million for Q2 2026 at Alector, up from $1.4 million in the prior quarter.
- Over five years, Accounts Payables peaked at $6.8 million in Q1 2022 and troughed at $1.4 million in Q1 2026.
- A 5-year average of $3.7 million and a median of $4.3 million in 2022 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 94.19% in 2022, down 61.1% in 2022.
- Over 5 years, Accounts Payables stood at $4.2 million in 2022, then decreased by 9.88% to $3.8 million in 2023, then slumped by 41.32% to $2.2 million in 2024, then retreated by 23.66% to $1.7 million in 2025, then jumped by 35.01% to $2.3 million in 2026.
- The last three Accounts Payables figures came in at $2.3 million (Q2 2026), $1.4 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 2.87 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 674.00 Mn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 429.50 Mn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 1.16 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 167.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 108.02 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 403.90 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 2.28 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.28 Mn |
| Mar 31, 2026 | 1.42 Mn |
| Dec 31, 2025 | 1.69 Mn |
| Sep 30, 2025 | 4.76 Mn |
| Jun 30, 2025 | 2.22 Mn |
| Mar 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.22 Mn |
| Sep 30, 2024 | 5.02 Mn |
| Jun 30, 2024 | 4.38 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 3.78 Mn |
| Sep 30, 2023 | 4.68 Mn |
| Jun 30, 2023 | 4.67 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 4.19 Mn |
| Sep 30, 2022 | 4.55 Mn |
| Jun 30, 2022 | 4.65 Mn |
| Mar 31, 2022 | 6.75 Mn |
| Dec 31, 2021 | 4.75 Mn |
| Sep 30, 2021 | 2.34 Mn |